In its second phase of clinical trials, the Russian vaccine against COVID-19, Sputnik V, will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation’s Drug Controller General (DCGI) told Sputnik on Thursday, reported Hindustan Times (HT).
It may be recalled, that last week, DCGI had granted permission to pharmaceutical giant Dr Reddy’s Laboratories for conducting the tests for Sputnik V in India.
“Dr Reddy’s Lab has stated that in phase 2 clinical trial would include 100 subjects and for phase 3, it would take 1400 subjects,” HT quoted a government official as saying.
“Once the pharma company would submit the safety and immunogenicity data of phase 2, it would be analysed by the expert panel and then they can proceed for the phase 3 trial,” the official added in the report.
Comments are closed.